Novavax starts COVID-19 vaccine trial for children aged six months to 11 years
U.S. biotech company Novavax, Inc., has started its phase 2b/3 Hummingbird global clinical trial. The…
The Covid-19 pandemic began as a few scattered cases in China, but within months, the respiratory infection had swept the world. The years 2020 and 2021 turned into a rollercoaster ride for the world’s population, with millions of people dead, livelihoods destroyed, and movement between countries plummeting.
Despite the strained situation, academic researchers and biotech and pharma companies globally have come together to develop protective vaccines and treatments against Covid-19. While we still have a long road ahead before this pandemic is declared over, the life sciences industry is bringing us closer to this moment with every new discovery, trial result, and fundraise. Read on to learn about the latest research, investments, trends, and pipeline developments.
European Biotech Industry Report 2021: A Year of European Biotechnology
This report discusses how the Covid-19 pandemic impacted Europe’s life science industry and covers recent market trends, investments, and collaborations in the biotech and pharma industry.
Go to ReportU.S. biotech company Novavax, Inc., has started its phase 2b/3 Hummingbird global clinical trial. The…
A randomized, placebo-controlled study in mild to moderate COVID-19 patients has been approved by the…
Researchers from Fujita Health University School of Medicine in Japan have been investigating COVID-19 to…
Vaccines for COVID-19 have saved lives all over the world, but their protection is threatened…
A biopharmaceutical company developing anti-inflammatory therapeutics announced today (July 26) that it is going to…
A study in Macao has found people taking the BioNTech mRNA vaccine as the third…
Lung immunity in the elderly will be the subject of a controlled clinical trial after…
Sinovac Biotech Ltd., a provider of biopharmaceutical products in China, has initiated a phase III…
South Korean company SK Bioscience has extended its partnership with Novavax, Inc., a U.S. biotechnology…
Amid worldwide disruptions caused by the COVID-19 pandemic, WHO and UNICEF report the largest continued…
Novavax, Inc. has been given emergency use authorization (EUA) by the U.S. Food and Drug…
This week’s guests are: Helen Zha, assistant professor of chemical and biological engineering and a…